Skip to main content

Biggest CoronaVirus spike in F1 ahead of Russian GP

SOCHI (Russia): Formula One confirmed on Friday that it has recorded the sport's biggest coronavirus spike this year as it prepares for the Russian Grand Prix, the 10th race of the season.

The sport said it had returned its highest number of positive Covid-19 test results, hours before welcoming a significant number of spectators to a race for the first time this year.

The F1 organisation and the sport's ruling body the International Motoring Federation (FIA) said they had discovered seven cases of coronavirus following 3,256 tests between September 18 and September 24.


The tests are carried out every five days on the teams' staff, drivers and all paddock and news media personnel.

This weekend's event is the first major international sports event of the Covid-19 era to have a significant crowd of spectators after the Russian promoters claim to have sold 30,000 tickets for Sunday's race.

Seven of the ten teams are based in Britain where the number of reported cases of infection has risen rapidly in recent weeks.

There had been 44,000 tests carried out during the opening nine races, run in a sequence of three triple-headers and under serious protocol for behaviour in bubbles - with a total of nine positive results overall and not more than two in a single week.

The practice of operating strict bubbles and sub-bubbles and restricting movement under tight guidelines faces its biggest test of the season this weekend.

Russia confirmed 7,212 new cases of Covid-19 on Friday to take the overall total to 1,136,048, according to The Moscow Times.


Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...